August 23, 2023
Exclusive: Bloomberg Technology’s Ed Ludlow Interviews Cellares’ CEO and Co-founder, Fabian Gerlinghaus on Company’s Massive $255M Series C Up-Round
Related News
-
June 10, 2026Cellares Joins New American Industrial Alliance, Advancing U.S. Biopharmaceutical Manufacturing Independence
-
June 09, 2026
Cathie Wood’s ARK Invest Joins Cellares’ $277 Million Series D
-
June 03, 2026
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
